mug105 Antibody

What is Mug105 and why is it significant in ubiquitin research?

Mug105 is a deubiquitinating enzyme from Schizosaccharomyces pombe that, along with human ZUFSP (also known as ZUP1), represents founding members of a novel DUB family distinct from the six previously known DUB classes. This protein is significant because it demonstrates a different structural organization and linkage specificity compared to other deubiquitinases. Mug105 has a minimalistic structure that lacks the ubiquitin-binding domains present in its human counterpart yet still maintains specific deubiquitinating activity .

Unlike human ZUFSP, which preferentially cleaves K63-linked ubiquitin chains, Mug105 selectively cleaves K48-linked chains with some residual activity against K63 and K11 linkages. This difference in specificity offers valuable insights into how structural elements influence substrate selection in deubiquitinating enzymes . The crystal structure of Mug105, resolved to 2.0 Å, reveals a globular α/β papain-fold structure similar to the ZUP1 catalytic core domain, providing important comparative data for understanding DUB evolution and functional adaptation .

How does the structure of Mug105 differ from human ZUFSP/ZUP1?

The structure of Mug105 bears striking resemblance to the ZUP1 catalytic core domain, with an RMSD of 1.7 Å over 215 residues, but with critical differences that affect function . Key structural differences include:

• Mug105 completely lacks all the ubiquitin-binding domains (UBDs) present in human ZUFSP, which explains its different linkage specificity .

• The active site residues (Cys-42, His-165, and Asp-183) in Mug105 assume a geometry similar to other papain-fold cysteine proteases, maintaining the catalytic functionality despite the absence of additional domains .

• The ubiquitin recognition site appears conserved between ZUP1 and Mug105, with Asp-89 of Mug105 corresponding to Asp-406 of ZUP1 (which forms a salt bridge with Arg-72 of ubiquitin) and Glu-109 of Mug105 corresponding to Glu-428 of ZUP1 (forming a salt bridge with Arg-74 of ubiquitin) .

• Mug105 contains Asp-185 at the position corresponding to Gly-514 in ZUP1 and Ser-528 in insect TcZUP, which affects enzymatic function differently across species .

• Certain residues like Trp-104 and Gln-163 in Mug105 show conformational flexibility that appears important for regulating access to the active site .

These structural differences contribute to the different substrate preferences and catalytic properties observed between Mug105 and human ZUFSP.

What are the recommended methods for detecting Mug105 using antibodies?

For efficient detection of Mug105 using antibodies, researchers should consider these methodological approaches:

• Western Blotting: Use denaturing conditions with SDS-PAGE followed by transfer to nitrocellulose or PVDF membranes. Mug105 has a molecular weight of approximately 26 kDa, and its covalent adduct with ubiquitin appears at ~34 kDa . Block membranes with 5% BSA in TBST rather than milk to avoid potential interference with enzyme detection.

• Immunoprecipitation: For pull-down experiments, use glutathione particles with 6His-GST tagged Mug105 (preferably the catalytically inactive C42A mutant to prevent substrate cleavage). Incubate in binding buffer containing 20 mM TRIS pH 7.5, 150 mM NaCl, 20 mM imidazole, and 0.1% NP-40 at 4°C .

• Activity-Based Detection: Complement antibody detection with activity-based probes such as Ub-PA (ubiquitin propargylamine) or K48-diUb-VME, which form covalent adducts with active Mug105. After reaction, these adducts can be detected using anti-ubiquitin antibodies (such as P4D1) or directly through gel-based methods .

• Controls: Always include recombinant Mug105 as a positive control and the catalytically inactive C42A mutant as a reference. For specificity validation, compare with samples where Mug105 is absent or knocked down .

• Visualization: For enhanced sensitivity, consider fluorescence-based detection systems, which offer better quantitative analysis than traditional chemiluminescence .

When working with antibodies against Mug105, thorough validation is essential to ensure specificity, particularly if the antibody might cross-react with human ZUFSP or other DUB family members.

How can I assess Mug105 deubiquitinase activity in experimental samples?

To assess Mug105 deubiquitinase activity in experimental samples, researchers can employ these complementary approaches:

• Fluorogenic Substrate Assays:

  • RLRGG-AMC Assay: Mug105 is highly active against this peptide substrate with kinetic parameters of KM = 12.2 μM and kcat = 7.2 s−1. This assay is particularly useful as most typical DUBs do not cleave this substrate efficiently .

  • Ubiquitin-AMC Assay: Mug105 cleaves this substrate with a specific activity of approximately 4.1 nmol substrate per mg enzyme per second .

• Chain Cleavage Assays:

  • Incubate purified K48-linked di-ubiquitin or polyubiquitin chains with Mug105, separate by SDS-PAGE, and detect with anti-ubiquitin antibodies .

  • Include controls with other linkage types (K63, K11) to confirm specificity .

• Covalent Probe Assays:

  • Treat samples with Ub-PA or K48-diUb-VME, which form covalent adducts specifically with active Mug105 .

  • Analyze by SDS-PAGE and detect with Coomassie staining or immunoblotting .

• Experimental Design Considerations:

  • Use freshly prepared reducing agents (DTT) to ensure optimal activity.

  • Include appropriate controls: catalytically inactive mutant (C42A), heat-inactivated enzyme, and inhibitor controls using cysteine protease inhibitors.

  • For cell lysates, use gentle lysis conditions to preserve enzymatic activity.

• Data Analysis:

  • For fluorogenic assays, calculate initial velocities from the linear portion of progress curves.

  • For chain cleavage assays, quantify band intensities by densitometry.

  • Normalize to total protein concentration for comparative analyses.

This multi-faceted approach provides comprehensive assessment of Mug105 activity, taking advantage of its distinctive preference for K48-linked chains and RLRGG-AMC substrate.

What mutations in Mug105 are informative for structure-function studies?

Several strategic mutations in Mug105 have provided valuable insights into its structure-function relationships:

• Active Site Mutations:

  • C42A: Mutation of the catalytic cysteine completely abolishes enzymatic activity. This mutant is particularly useful for binding studies without the complication of substrate cleavage .

  • H165A and D183A: These mutations target the other members of the catalytic triad and significantly impair enzymatic function .

• Ubiquitin Recognition Residues:

  • D89A: Disrupts the interaction with Arg-72 of ubiquitin, affecting substrate recognition .

  • E109A: Impairs binding to Arg-74 of ubiquitin, also crucial for substrate recognition .

  • Q215A: This mutation reduces activity against both the RLRGG-AMC peptide and K48 chains. The corresponding residue (Gln-547) in human ZUP1 interacts with Arg-42 of ubiquitin .

• Conformationally Important Residues:

  • W104A: This tryptophan undergoes significant conformational change upon ubiquitin binding. In the unbound state, it blocks the substrate-binding cleft. Mutation dramatically reduces activity, highlighting its crucial role in substrate accommodation .

  • Q163A: This glutamine shows conformational flexibility and appears important for Mug105 function, as its mutation causes substantial activity loss .

• Species-Specific Position 185:

  • D185S: This position is occupied by different residues across species (Asp-185 in Mug105, Gly-514 in human ZUP1, Ser-528 in insect TcZUP). Interestingly, while the D185S mutation doesn't improve Mug105 activity, introducing aspartate at the corresponding positions in human and insect orthologs reduces their activity .

These mutations provide an essential toolkit for dissecting the molecular mechanisms of Mug105 function and understanding the structural basis of its unique specificity compared to other DUB family members.

How can I differentiate between Mug105 activity and other DUBs in complex biological samples?

Differentiating Mug105 activity from other DUBs in complex biological samples requires a strategic approach leveraging its unique characteristics:

• Linkage Specificity Profiling:

  • Mug105 strongly prefers K48-linked chains, with minimal activity toward K63 and K11 linkages .

  • Test activity against a panel of defined linkage-type di-ubiquitin chains to create a distinctive "fingerprint."

  • Compare cleavage patterns with known profiles of other DUBs with different specificities .

• Substrate Probe Specificity:

  • Mug105 reacts with Ub-PA and K48-diUb-VME probes, but not with K63-diUb-VME .

  • It does not react with UBL protease probes like UFM1-PA or LC3B-PA, unlike UFSP2 or ATG4B respectively .

  • This distinctive reactivity profile can help identify Mug105-specific activity.

• Unique Peptide Substrate Utilization:

  • Unlike typical DUBs, Mug105 is highly active against the RLRGG-AMC peptide substrate (KM = 12.2 μM, kcat = 7.2 s−1) .

  • Standard DUBs like USP21 require an intact ubiquitin moiety and do not cleave this peptide efficiently .

  • This differential peptide substrate preference provides a convenient distinguishing feature.

• Inhibitor Sensitivity Patterns:

  • Mug105 lacks the additional ubiquitin-binding domains present in many DUBs.

  • This structural difference may confer distinct inhibitor sensitivity patterns that can be exploited for differentiation.

• Immunodepletion Approach:

  • Use Mug105-specific antibodies to immunodeplete the enzyme from samples.

  • Compare activity profiles before and after depletion to identify Mug105-specific contribution.

• Chain Length Independence:

  • Unlike human ZUFSP, Mug105 does not show enhanced activity toward very long ubiquitin chains .

  • This property can help distinguish it from ZUFSP and other length-dependent DUBs.

By combining these approaches and incorporating appropriate controls, researchers can reliably attribute specific DUB activities to Mug105 even in complex biological samples containing multiple DUB enzymes.

What conformational changes occur in Mug105 upon ubiquitin binding?

The structural data reveals important conformational changes in Mug105 associated with ubiquitin binding that likely regulate enzyme function:

• Tryptophan Gate Mechanism:

  • Trp-104 in Mug105 (corresponding to Trp-423 in ZUP1 and Trp-443 in TcZUP) undergoes a significant conformational change upon ubiquitin binding .

  • In the ubiquitin-free Mug105 structure, Trp-104 adopts a conformation that blocks the substrate-binding cleft .

  • Upon ubiquitin binding, this residue likely repositions to accommodate the substrate, as observed in ubiquitin-bound structures of ZUP1 and TcZUP .

  • The W104A mutation dramatically reduces activity in both peptide and chain cleavage assays, highlighting its critical role .

• Glutamine Repositioning:

  • Gln-163 in Mug105 (corresponding to Gln-489 in ZUP1 and Gln-503 in TcZUP) assumes a different orientation in the ubiquitin-free structure compared to the ubiquitin-bound forms of the other enzymes .

  • In ZUP1 and TcZUP, this glutamine forms a weak interaction with Arg-74 of ubiquitin .

  • Interestingly, while Q489A mutation in ZUP1 and the corresponding mutation in TcZUP have minimal effects on activity, the Q163A mutation in Mug105 causes substantial activity loss .

  • This suggests species-specific adaptations in the functional importance of this residue.

• Active Site Accessibility Regulation:

  • These conformational changes appear to regulate access to the active site, potentially serving as a substrate-induced activation mechanism .

  • This regulatory mechanism may prevent nonspecific proteolysis, ensuring that the enzyme is fully active only when engaged with its proper substrate.

• Ubiquitin C-terminal Recognition:

  • The recognition site for the ubiquitin C-terminal R-x-R motif appears conserved between ZUP1 and Mug105 .

  • Asp-89 and Glu-109 in Mug105 form salt bridges with Arg-72 and Arg-74 of ubiquitin, respectively, similar to their counterparts in ZUP1 .

  • These interactions likely help position the ubiquitin C-terminus correctly in the active site.

These substrate-induced conformational changes represent an important regulatory mechanism that may be conserved across ZUFSP family members, though with species-specific adaptations that influence substrate recognition specificity and catalytic efficiency.

What experimental approaches can assess Mug105 binding to different ubiquitin chain types?

To comprehensively assess Mug105 binding to different ubiquitin chain types, researchers can employ these sophisticated experimental approaches:

• Pull-down Binding Assays:

  • Use glutathione particles with 6His-GST tagged catalytically inactive Mug105 (C42A) to prevent substrate cleavage during binding studies .

  • Incubate beads with different ubiquitin chain types in binding buffer (20 mM TRIS pH 7.5, 150 mM NaCl, 20 mM imidazole, and 0.1% NP-40) at 4°C .

  • After washing, analyze bound chains by SDS-PAGE followed by Coomassie staining or immunoblotting with anti-ubiquitin antibodies (such as P4D1) .

  • Compare binding profiles across different linkage types (K48, K63, K11, etc.) and chain lengths.

• Biophysical Interaction Analysis:

  • Surface Plasmon Resonance (SPR): Immobilize Mug105 C42A on a sensor chip and flow ubiquitin chains across to measure binding kinetics (kon, koff) and affinity (KD).

  • Isothermal Titration Calorimetry (ITC): Determine thermodynamic parameters (ΔH, ΔS, ΔG) and stoichiometry of Mug105-ubiquitin chain interactions.

  • Microscale Thermophoresis (MST): Measure interactions in solution with minimal protein consumption, useful for comparing affinities across multiple chain types.

• Structural Approaches:

  • X-ray Crystallography: Attempt co-crystallization of Mug105 C42A with various ubiquitin chains to determine binding interfaces at atomic resolution.

  • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): Map regions of Mug105 with altered solvent accessibility upon binding different chain types to identify interaction surfaces.

  • Cryo-Electron Microscopy: For larger complexes, especially with longer chains, cryo-EM might reveal binding modes not captured by crystallography.

• Mutagenesis-Based Approaches:

  • Generate mutations at potential binding interfaces based on structural predictions and test their effects on chain binding.

  • Focus on residues like D89, E109, W104, and Q163 that appear important for ubiquitin recognition .

  • Create chimeric proteins with domains swapped between Mug105 and ZUFSP to identify regions responsible for different chain preferences.

• Competition Assays:

  • Use fluorescently labeled ubiquitin chains as tracers in competition assays with unlabeled chains.

  • This approach can provide relative affinities for different chain types in a single experimental setup.

These complementary approaches provide a comprehensive assessment of Mug105's interaction with different ubiquitin chain types, helping uncover the molecular basis for its K48 linkage preference despite lacking conventional ubiquitin-binding domains.

What are common challenges when working with Mug105 antibodies and how can they be addressed?

When working with Mug105 antibodies, researchers may encounter several technical challenges that require specific troubleshooting approaches:

• Cross-Reactivity Issues:

  • Challenge: Antibodies may cross-react with human ZUFSP/ZUP1 or other DUB family members due to structural similarity (RMSD of 1.7 Å between Mug105 and ZUP1 catalytic domains) .

  • Solution: Validate antibody specificity using recombinant proteins and knockout/knockdown controls. Consider using epitope-tagged Mug105 and tag-specific antibodies for cleaner detection.

• Low Signal Intensity:

  • Challenge: Endogenous Mug105 expression levels may be low, resulting in weak detection signals.

  • Solution: Use signal amplification techniques such as HRP-polymer detection systems or tyramide signal amplification. For western blots, extend primary antibody incubation to overnight at 4°C and optimize antibody concentration through titration experiments.

• High Background in Immunodetection:

  • Challenge: Non-specific binding leading to high background, especially with polyclonal antibodies.

  • Solution: Use more stringent blocking (5% BSA instead of milk) and increase washing steps. Include 0.1-0.5% Tween-20 in wash buffers, and consider pre-absorbing antibodies with extracts from Mug105-deficient cells.

• Conformational Epitope Masking:

  • Challenge: Some epitopes may be masked due to conformational changes when Mug105 is bound to ubiquitin or in different functional states .

  • Solution: Use multiple antibodies targeting different epitopes. For fixed-cell applications, test different fixation methods (paraformaldehyde vs. methanol) that may preserve different epitopes.

• Protein-Protein Interactions Interfering with Detection:

  • Challenge: Interactions with ubiquitin chains or other proteins may block antibody accessibility.

  • Solution: Include denaturants (SDS) for western blotting. For co-immunoprecipitation, consider crosslinking approaches or mild detergents that preserve interactions but improve antibody accessibility.

• Quality Control for Reproducible Results:

  • Challenge: Lot-to-lot variability in antibodies leading to inconsistent results.

  • Solution: Validate each new antibody lot against a standard sample. Maintain detailed records of optimal conditions for each lot, and consider pooling antibody stocks to minimize variation.

These strategies can help overcome common technical challenges when working with Mug105 antibodies, improving detection specificity, sensitivity, and reproducibility in various experimental applications.

How can I optimize expression and purification of recombinant Mug105 for antibody production?

Optimizing the expression and purification of recombinant Mug105 for antibody production requires careful attention to several key factors:

• Expression Construct Design:

  • Vector Selection: Use pET-based vectors for bacterial expression with T7 promoter for high-level induction.

  • Affinity Tags: Incorporate an N-terminal 6His-GST tag for dual purification strategy and enhanced solubility .

  • Cleavage Sites: Include a TEV protease recognition sequence between the tag and Mug105 for tag removal if needed.

  • Sequence Verification: Confirm the construct is in-frame and lacks mutations, especially in the catalytic residues (Cys-42, His-165, Asp-183) .

• Optimized Expression Conditions:

  • Bacterial Strain: Use BL21(DE3) or Rosetta(DE3) for enhanced expression of eukaryotic proteins.

  • Growth Temperature: Express at lower temperature (18°C) after IPTG induction to enhance proper folding.

  • Induction Protocol:

    • Grow cultures to OD600 of 0.6-0.8

    • Induce with 0.2-0.5 mM IPTG

    • Continue expression for 16-18 hours at 18°C

  • Media Optimization: Try auto-induction media for higher yields without manual induction.

• Efficient Purification Strategy:

  • Lysis Conditions: Use buffer containing 20 mM TRIS pH 7.5, 150 mM NaCl, 20 mM imidazole, and protease inhibitors .

  • Two-Step Affinity Purification:

    • Ni-NTA chromatography for His-tag capture

    • Glutathione affinity chromatography for further purification of GST-fusion protein

  • Size Exclusion Chromatography: Final polishing step to ensure homogeneity and remove aggregates.

  • Quality Control: Assess purity by SDS-PAGE (>95%) and verify identity by mass spectrometry.

• Protein Stability Considerations:

  • Reducing Agents: Include 1-5 mM DTT or TCEP in all buffers to maintain the catalytic cysteine in reduced state.

  • Storage Buffer: 20 mM TRIS pH 7.5, 150 mM NaCl, 1 mM DTT, 10% glycerol.

  • Storage Conditions: Flash-freeze small aliquots and store at -80°C to avoid repeated freeze-thaw cycles.

  • Activity Verification: Confirm enzymatic activity using RLRGG-AMC assay before immunization .

• Antigen Preparation for Immunization:

  • Full-length vs. Peptide: For polyclonal antibodies, use purified full-length protein; for monoclonals, consider both full protein and unique peptide sequences.

  • Denatured vs. Native: For detecting denatured protein (western blot), immunize with SDS-treated protein; for applications requiring native detection, immunize with properly folded protein.

  • Cross-adsorption Strategy: To minimize cross-reactivity with ZUP1/ZUFSP, consider cross-adsorbing antibodies with the human ortholog.

By optimizing these parameters, researchers can obtain high-quality recombinant Mug105 that serves as an excellent antigen for antibody production, leading to specific and sensitive detection reagents for subsequent research applications.

What controls are essential when validating Mug105 antibody specificity?

Thorough validation of Mug105 antibody specificity requires a comprehensive set of controls to ensure reliable and reproducible results:

• Positive Controls:

  • Recombinant Protein: Purified recombinant Mug105 at known concentrations serves as the gold standard positive control .

  • Overexpression Systems: Cells transfected with Mug105 expression constructs, preferably with epitope tags for independent verification.

  • Native Source: S. pombe extracts (where Mug105 is endogenously expressed) compared with extracts from other species lacking the protein.

• Negative Controls:

  • Knockout/Knockdown Validation: S. pombe strains with Mug105 gene deletion or RNAi-mediated knockdown.

  • Pre-immune Serum: For polyclonal antibodies, the pre-immune serum should show no reactivity.

  • Isotype Control: For monoclonal antibodies, an irrelevant antibody of the same isotype.

  • Secondary Antibody Only: Controls for non-specific binding of secondary detection reagents.

• Specificity Controls:

  • Cross-reactivity Assessment: Test against human ZUFSP/ZUP1 and other related DUBs to ensure specificity, particularly important given the structural similarity (RMSD 1.7 Å) between Mug105 and the ZUP1 catalytic domain .

  • Pre-absorption Test: Pre-incubate antibody with excess recombinant Mug105 before use; specific signals should disappear.

  • Peptide Competition: If the antibody was raised against a specific peptide, competition with excess free peptide should block specific binding.

• Validation Across Multiple Applications:

  • Western Blot: Verify single band of expected molecular weight (~26 kDa for Mug105), with shifted band (~34 kDa) when covalently bound to ubiquitin .

  • Immunoprecipitation: Confirm ability to selectively enrich Mug105 from complex mixtures.

  • Immunofluorescence: Demonstrate specific subcellular localization pattern that disappears in knockout controls.

• Functional Validation:

  • Activity Correlation: Show that antibody detection correlates with biochemical activity assessed by RLRGG-AMC or Ub-AMC cleavage .

  • Activity Interference Test: Determine whether antibody binding affects enzyme activity, which is important when using antibodies in functional studies.

  • Immunodepletion Effect: Demonstrate that immunodepletion with the antibody removes Mug105 activity from extracts.

• Validation Data Documentation:

  • Maintain comprehensive records of all validation experiments.

  • Document lot-to-lot variation and optimal working conditions.

  • Consider publishing validation data as supplementary material in research papers.

These rigorous validation controls ensure that experimental observations attributed to Mug105 are genuine and not artifacts of non-specific antibody interactions, critical for maintaining scientific integrity in research involving this important deubiquitinating enzyme.

How do conformational dynamics of Mug105 compare to other ZUFSP family members?

The conformational dynamics of Mug105 reveal fascinating similarities and differences compared to other ZUFSP family members, providing insights into evolutionary adaptation of enzyme function:

• Conserved Conformational Switches:

  • Tryptophan Gate Mechanism: Trp-104 in Mug105, Trp-423 in human ZUP1, and Trp-443 in insect TcZUP all appear to function as conformational switches . In the ubiquitin-free Mug105 structure, this tryptophan adopts a conformation that blocks the substrate-binding cleft, while in ubiquitin-bound ZUP1 and TcZUP structures, it repositions to accommodate the substrate .

  • Functional Conservation: The W104A mutation in Mug105, like corresponding mutations in ZUP1 and TcZUP, dramatically reduces activity against both peptide substrates and ubiquitin chains, indicating functional conservation of this conformational switch despite sequence divergence .

• Divergent Glutamine Dynamics:

  • Structural Differences: Gln-163 in Mug105 (corresponding to Gln-489 in ZUP1 and Gln-503 in TcZUP) assumes a different orientation in the ubiquitin-free structure compared to the ubiquitin-bound forms of other enzymes .

  • Functional Divergence: While Q489A mutation in ZUP1 and the corresponding mutation in TcZUP have minimal effects on activity, the Q163A mutation in Mug105 causes substantial activity loss . This suggests that despite structural conservation, the functional importance of this residue has diverged among family members.

• Substrate-Induced Conformational Changes:

  • The available structural data suggests that conformational changes in Mug105 are not species-specific differences but rather represent substrate-induced conformational changes .

  • This substrate-induced activation mechanism likely prevents nonspecific proteolysis and ensures proper target recognition.

• Linkage Specificity Determinants:

  • Despite similar core catalytic domain structures, Mug105 preferentially cleaves K48-linked chains while human ZUFSP prefers K63 chains .

  • This specificity difference appears to be mediated by additional modular ubiquitin-binding domains present in ZUFSP but absent in Mug105, rather than by differences in conformational dynamics of the catalytic core .

• Position 185 Variation:

  • Asp-185 in Mug105 corresponds to Gly-514 in human ZUP1 and Ser-528 in insect TcZUP .

  • Unlike the beneficial effects of serine at this position in some orthologs, the D185S mutation doesn't improve Mug105 activity, indicating context-dependent functional effects of this residue .

These comparative analyses of conformational dynamics provide crucial insights into how conserved structural elements have been adapted for different functional specificities throughout evolution of the ZUFSP family, highlighting the interplay between structure, dynamics, and function in enzyme adaptation.

What is the evolutionary relationship between Mug105 and other deubiquitinating enzyme families?

The evolutionary relationship between Mug105 and other deubiquitinating enzyme families reveals fascinating insights into the diversification of ubiquitin processing enzymes:

This evolutionary analysis highlights how a conserved catalytic core can be adapted through domain acquisition and subtle structural changes to create diversified enzyme functions across different species, contributing to the complexity of the ubiquitin system throughout eukaryotic evolution.